Pharma Focus Asia

WuXi Biologics Partners with Pharmadule Morimatsu

Tuesday, June 27, 2023

WuXi Biologics has announced a global strategic partnership with Pharmadule Morimatsu for its Singapore-based Contract Development and Manufacturing Organisation (CRDMO) Centre Project.

The partnership between Pharmadule Morimatsu and WuXi Biologics provides modular facilities for the WuXi Biologics Singapore CRDMO Centre project. This collaboration aims to support WuXi Biologics in expanding its production capacity, accelerating the empowerment of global pharmaceutical companies, reducing research and development (R&D) costs, and ultimately benefiting patients worldwide.

The collaboration between the Singapore CRDMO Centre and Pharmadule Morimatsu allows to leverage their expertise and experience in establishing global sites successfully demonstrated by the greenfield site in Ireland, further enhancing the ability to serve global partners with premier quality services and solutions.

The CRDMO centre in Singapore adopts new generation of modular fabrication and perform the majority of construction work at Morimatsu's workshop and brings several advantages in terms of quality, schedule, cost, and risk management.

magazine-slider-imageMFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Advance DoE WorkshopNitrosamine Advance Workshop 2024CPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024LogiPharma Asia 2024